(Q48607830)

13 February 2018

title

Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice (English)

1 reference

13 February 2018

author

Yi-Hsiang Huang

5

1 reference

13 February 2018

author name string

Kuei-Chuan Lee

1

1 reference

13 February 2018

Che-Chang Chan

2

1 reference

13 February 2018

Ying-Ying Yang

3

1 reference

13 February 2018

Yun-Cheng Hsieh

4

1 reference

13 February 2018

Han-Chieh Lin

6

1 reference

13 February 2018

publication date

23 September 2012

1 reference

13 February 2018

European Journal of Clinical Investigation

published in

1 reference

13 February 2018

volume

42

1 reference

13 February 2018

issue

12

1 reference

13 February 2018

page(s)

1261-1271

1 reference

13 February 2018

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

1 reference

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Renin inhibition in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Structure-based design of aliskiren, a novel orally effective renin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Clinical pharmacokinetics and pharmacodynamics of aliskiren

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Bile salt-induced apoptosis involves NADPH oxidase isoform activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Role of Kupffer cells in host defense and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Aliskiren accumulates in Renin secretory granules and binds plasma prorenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

The biology of the (pro)renin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02725.X

10.1111/J.1365-2362.2012.02725.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018